Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patient focused benefit risk assessment�� why when how should epidemiologists get
… diagnosis and regular monitoring, all of which can improve patient outcomes. Biopharma can use these data for research purposes, such as understanding how their product performs in real-world settings, … research, including RWE, patient-centered outcomes assessment, epidemiology, evidence synthesis, and economic …
… published in Pediatrics give us an updated picture of how well childhood immunizations prevent disease and the … economic benefits of the studied vaccines. Read more about why and how these studies were conducted and their results by …
… Attendees will come away with a greater understanding of why using inclusive language is crucial in contemporary biomedical research and communications and how these best practices can strengthen demographic … language in life science research and communications How RTI Health Solutions uses inclusive language best …
… of hematologic diseases. Recent projects have included: Benefit-risk preference studies Decision-analytic models (cost … Global Value Dossiers Literature reviews Measurement of patient preferences for treatment options Observational …
… Trends in the Inclusion of Patient Reported Outcomes in Oncology Clinical Trials … 29% of industry sponsored oncology trials included assessment of PROs. Over the last five years, the US FDA has … voice in drug development and has issued new guidelines on how to do so. At the same time, the health care industry has …
… HCPs towards hepatitis A and B vaccination of adults at risk. Shamarina D, Sluga-O'Callaghan M, Dave V, Davenport E, …
… Asset Value Through Evidence Generation Planning When developing new products to treat rare diseases, it is … product value to support successful reimbursement and patient access. Creating a strategic plan with a Market … payers, regulators, providers, and patients. Who can benefit from early market access planning for rare disease …
… of rheumatology diseases. Recent projects have included: Benefit-risk preference studies Decision-analytic models (cost … quality-of-life analyses Literature reviews Measurement of patient preferences for treatment options Observational …
… treatment of CV illnesses. Recent projects have included: Benefit-risk preference studies Cohort and case-control studies … of risk management plans Literature reviews Measurement of patient preferences for treatment options Meta-analysis …
… arising from treatment of respiratory illnesses. Benefit-risk preference studies Consulting on drug development and … research strategy development Physician and payer research Patient-reported outcomes instrument development and …